These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 6369517)
1. GIP and insulin responses to a test meal in healthy and obese subjects. Jorde R; Amland PF; Burhol PG; Giercksky KE; Ebert R Scand J Gastroenterol; 1983 Nov; 18(8):1115-9. PubMed ID: 6369517 [TBL] [Abstract][Full Text] [Related]
2. Gastric inhibitory polypeptide in obesity and diabetes mellitus. Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812 [TBL] [Abstract][Full Text] [Related]
3. Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia. Ebert R; Creutzfeldt W Acta Diabetol Lat; 1989; 26(1):1-15. PubMed ID: 2665406 [TBL] [Abstract][Full Text] [Related]
4. The effect of a 34-h fast on the meal-induced rises in plasma GIP, serum insulin, and blood glucose in man. Jorde R; Burhol PG; Schulz TB; Waldum HL; Lygren I; Jenssen T; Myhre ES Scand J Gastroenterol; 1981; 16(1):109-12. PubMed ID: 7015476 [TBL] [Abstract][Full Text] [Related]
5. Effects of diet on insulin and gastric inhibitory polypeptide levels in obese children. Deschamps I; Heptner W; Desjeux JF; Baltakse V; Machinot S; Lestradet H Pediatr Res; 1980 Apr; 14(4 Pt 1):300-3. PubMed ID: 6990366 [TBL] [Abstract][Full Text] [Related]
6. The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man. Jorde R; Waldum HL; Burhol PG; Lygren I; Schulz TB; Florholmen J; Jenssen TG Scand J Gastroenterol; 1981; 16(1):113-9. PubMed ID: 6112787 [TBL] [Abstract][Full Text] [Related]
7. Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus. Mazzaferri EL; Starich GH; Lardinois CK; Bowen GD J Clin Endocrinol Metab; 1985 Aug; 61(2):313-21. PubMed ID: 4008608 [TBL] [Abstract][Full Text] [Related]
16. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related]
17. Failure of fasting to influence the GIP response to oral glucose in non-obese human subjects. Andrews WJ; Henry RW; Alam MJ; Alberti KG; Buchanan KD Diabetologia; 1983 Oct; 25(4):372-4. PubMed ID: 6357919 [TBL] [Abstract][Full Text] [Related]
18. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity. Salera M; Giacomoni P; Pironi L; Cornia G; Capelli M; Marini A; Benfenati F; Miglioli M; Barbara L J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154 [TBL] [Abstract][Full Text] [Related]
19. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon. Ebert R; Arnold R; Creutzfeldt W Gut; 1977 Feb; 18(2):121-7. PubMed ID: 856672 [TBL] [Abstract][Full Text] [Related]
20. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. Stock S; Leichner P; Wong AC; Ghatei MA; Kieffer TJ; Bloom SR; Chanoine JP J Clin Endocrinol Metab; 2005 Apr; 90(4):2161-8. PubMed ID: 15657373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]